fixes

Author: jarochi

docs/subsite/projects/AMI-cryoEM.html

@@ -436,7 +436,7 @@ <h2 class="anchored" data-anchor-id="amicryoml-unraveling-amyloid-polymorphism">
 <strong>Grant ID</strong>: 101244706<br>
 <strong>Start Date</strong>: 1 Feb 2026<br>
 <strong>Duration</strong>: 24 months<br>
-<strong>EU Contribution</strong>: €181136.16</p>
+<strong>EU Contribution</strong>: €181,136.16</p>
 <p>Neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and prion diseases are marked by protein misfolding into amyloid fibrils. The structural diversity (polymorphism) of these fibrils critically affects their pathology, yet remains largely unexplored. AMI‑CryoML bridges cryo‑EM and machine learning to probe how small molecule modulators influence aggregation kinetics and amyloid structures.</p>
 <section id="project-highlights" class="level3">
 <h3 class="anchored" data-anchor-id="project-highlights">📌 Project highlights</h3>

docs/subsite/projects/OneTick.html

@@ -433,11 +433,11 @@ <h1 class="title">OneTick</h1>
 <section id="onetick-one-health-approach-to-tickborne-diseases" class="level2">
 <h2 class="anchored" data-anchor-id="onetick-one-health-approach-to-tickborne-diseases">🧬 OneTick: One Health approach to tick‑borne diseases</h2>
 <p><strong>OneTick: An Integrated One Health Approach for Prevention, Detection and Treatment of Tick‑Borne Diseases in Urban and Peri‑Urban Environments</strong></p>
-<p><strong>PI</strong>: Michał <strong>Proposal development</strong>: Michał, Jarosław, Valen<br>
+<p><strong>PI</strong>: Michał <strong>Proposal development</strong>: Michał, Jarek, Valen<br>
 <strong>Grant ID</strong>: 101236599<br>
 <strong>Start Date</strong>: 1 Jan 2026<br>
 <strong>Duration</strong>: 48 months<br>
-<strong>EU Contribution</strong>: €450900.00</p>
+<strong>EU Contribution</strong>: €450,900.00</p>
 <p>Tick‑borne diseases (TBDs) such as Lyme disease and TBE are on the rise in Europe due to shifts in climate and urbanization. In 2022, some 24% of Europeans resided in high‑risk Lyme areas, and the ECDC estimated ~360,000 cases in 2016, costing about €280M annually. OneTick advances prevention, detection and treatment within a One Health framework, targeting urban and peri‑urban areas.</p>
 <section id="project-highlights" class="level3">
 <h3 class="anchored" data-anchor-id="project-highlights">📌 Project Highlights</h3>

subsite/projects/AMI-cryoEM.qmd

@@ -14,7 +14,7 @@ editor:
 **Grant ID**: 101244706  
 **Start Date**: 1 Feb 2026  
 **Duration**: 24 months  
-**EU Contribution**: €181136.16  
+**EU Contribution**: €181,136.16  
 
 Neurodegenerative disorders such as Alzheimer's, Parkinson’s, and prion diseases are marked by protein misfolding into amyloid fibrils. The structural diversity (polymorphism) of these fibrils critically affects their pathology, yet remains largely unexplored. AMI‑CryoML bridges cryo‑EM and machine learning to probe how small molecule modulators influence aggregation kinetics and amyloid structures.
 

subsite/projects/OneTick.qmd

@@ -11,11 +11,11 @@ editor:
 **OneTick: An Integrated One Health Approach for Prevention, Detection and Treatment of Tick‑Borne Diseases in Urban and Peri‑Urban Environments**
 
 **PI**: Michał
-**Proposal development**: Michał, Jarosław, Valen  
+**Proposal development**: Michał, Jarek, Valen  
 **Grant ID**: 101236599  
 **Start Date**: 1 Jan 2026  
 **Duration**: 48 months  
-**EU Contribution**: €450900.00  
+**EU Contribution**: €450,900.00  
 
 Tick‑borne diseases (TBDs) such as Lyme disease and TBE are on the rise in Europe due to shifts in climate and urbanization. In 2022, some 24% of Europeans resided in high‑risk Lyme areas, and the ECDC estimated ~360,000 cases in 2016, costing about €280M annually. OneTick advances prevention, detection and treatment within a One Health framework, targeting urban and peri‑urban areas.